Cannalyze
Database of Cannabis Strains, Compounds, and Potency
Company Overview
Snapshot
Founded in February 2019 by Moshe Keva and Erel Kapah, Cannalyze operated with 1–10 employees. The company ceased operations in January 2020.
Business overview
Cannalyze was developing an AI-based database of lab-tested cannabis compounds to provide consumers, caregivers, growers, and dispensaries with data on product-specific potential effects. Its core technology aimed to make compound data accessible, enabling dispensaries to inform customers, providing growers with product feedback, and assisting caregivers in prescribing appropriate strains. The company operated within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support, targeting consumers, healthcare providers, and laboratories in the cannabis market.
Log in to access full profile ›Company Intelligence Q&A
- What is Cannalyze's primary focus?
- Cannalyze focuses on developing an AI-based database of lab-tested cannabis compounds to provide data on product-specific potential effects to consumers, caregivers, growers, and dispensaries.
- When was Cannalyze founded?
- Cannalyze was founded in February 2019.
- Who are the founders of Cannalyze?
- The co-founders of Cannalyze are Moshe Keva and Erel Kapah.
- In which sector does Cannalyze operate?
- Cannalyze operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Medical Decision Support.
- What was the operational status of Cannalyze?
- Cannalyze ceased to operate in January 2020.